These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8744469)

  • 1. Compatibility of selected critical care drugs during simulated Y-site administration.
    Yamashita SK; Walker SE; Choudhury T; Iazzetta J
    Am J Health Syst Pharm; 1996 May; 53(9):1048-51. PubMed ID: 8744469
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents.
    Newland AM; Mauro VF; Alexander KS
    Am J Health Syst Pharm; 2009 Jun; 66(11):986-7. PubMed ID: 19451606
    [No Abstract]   [Full Text] [Related]  

  • 3. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
    Allen LV; Levinson RS; Phisutsinthop D
    Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
    Baltz JK; Kennedy P; Minor JR; Gallelli J
    Am J Hosp Pharm; 1990 Sep; 47(9):2075-7. PubMed ID: 2145761
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
    Kumar A; Mann HJ
    Am J Health Syst Pharm; 2010 Oct; 67(19):1640-4. PubMed ID: 20852166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.
    Sprandel KA; Styrczula DE; Deyo K; Sibley C; Rodvold KA
    Am J Health Syst Pharm; 2005 Jan; 62(1):88-92. PubMed ID: 15658079
    [No Abstract]   [Full Text] [Related]  

  • 7. Compatibility of commonly used intravenous infusions in a pediatric intensive care unit.
    Wedekind CA; Fidler BD
    Crit Care Nurse; 2001 Aug; 21(4):45-51. PubMed ID: 11858688
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical incompatibility of parenteral drug admixtures.
    McCarthy TJ
    S Afr Med J; 1974 Sep; 48(46):1951-3. PubMed ID: 4421027
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual compatibility of sodium nitroprusside with other injectable medications given to pediatric patients.
    Seto W; Trope A; Carfrae L; Walker S
    Am J Health Syst Pharm; 2001 Aug; 58(15):1422-6. PubMed ID: 11494788
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physicochemical incompatibilities of injectable drugs].
    Hoffman M; Hazebroucq G
    Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual compatibility of gallium nitrate with selected drugs during simulated Y-site injection.
    Lober CA; Dollard PA
    Am J Hosp Pharm; 1993 Jun; 50(6):1208-10. PubMed ID: 8517464
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
    Marquardt ED; Lam SS
    Am J Hosp Pharm; 1994 Mar; 51(6):811-2. PubMed ID: 8010323
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual compatibility of i.v. medications routinely used in bone marrow transplant recipients.
    Canann D; Tyler LS; Barker B; Condie C
    Am J Health Syst Pharm; 2009 Apr; 66(8):727-9. PubMed ID: 19336832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
    Trissel LA; Tramonte SM; Grilley BJ
    Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
    [No Abstract]   [Full Text] [Related]  

  • 16. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
    Swart EL; Mooren RA; van Loenen AC
    Am J Health Syst Pharm; 1995 Sep; 52(18):2020-2. PubMed ID: 8528872
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidrug infusions in a Swiss palliative care unit: assessment of frequent combinations in terms of clinical effectiveness, compatibility, and stability.
    Fusi-Schmidhauser T; Caronzolo D; Gamondi C
    Support Care Cancer; 2016 Dec; 24(12):4971-4978. PubMed ID: 27448404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery.
    Voytilla KL; Tyler LS; Rusho WJ
    Am J Health Syst Pharm; 2002 May; 59(9):853-5. PubMed ID: 12004465
    [No Abstract]   [Full Text] [Related]  

  • 19. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Jan; 54(1):56-60. PubMed ID: 9117791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.